The estimated net worth of Jason Paul Steik is at least $18,491 dollars as of 31 Jul 2025. Jason Paul Steik is the Chief Clinical Officer of Pennant Group, Inc. and owns shares of Pennant Group, Inc. (PNTG) stock worth about $18.5K.
There are no insider transactions reported by Jason Paul Steik
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.